Mississippi lawmakers send bill that criminalizes abortion-inducing medication to governor
Context:
Mississippi lawmakers advanced a bill that criminalizes distribution of abortion-inducing medication, potentially imprisoning violators for up to 10 years as it moves to Governor Tate Reeves. The measure, added to a drug trafficking bill, aims to close gaps over how abortion drugs enter the state, even as critics warn it could chill legitimate medical use and deter doctors. Experts say cross-border enforcement is unlikely to succeed and the law’s vague language could sweep up individuals for personal use. The move reflects a broader post-Dobbs effort to enforce Mississippi’s abortion ban, with opposition framing it as harmful to low-income residents and medical autonomy. The outcome hinges on the governor’s decision and future legal interpretations.
Dive Deeper:
The abortion-inducing drug provisions were added to a drug trafficking bill that passed the House 76-38 and the Senate 37-15, with Republicans controlling both chambers, and now await Gov. Tate Reeves' signature.
Penalties could reach up to 10 years in prison for distributing abortion-inducing medication, with charges expanding to individuals who intend to distribute, not just those who do distribute.
Mary Ziegler of UC Davis Law notes that prosecutions against out-of-state providers would be difficult given shield laws and interstate limits, suggesting prosecutions may target local actors more than distant ones.
The bill’s language is criticized for vagueness: possession could be criminalized based on intent to distribute, and even doctors could face prosecution under unclear conditions around prescribing for miscarriage or hemorrhage.
Experts argue the law may chill legitimate clinical practice and drug research, since intent to abort becomes the key, a standard hard to prove in medical settings, creating a chilling effect on care.
Lawmakers cited concerns about circumvention via mail or cross-state sourcing, framing the measure as enforcing Mississippi’s pro-life stance even as opponents warn of broader harm to patients, particularly the poor.